Rapid Micro Biosystems (NASDAQ:RPID) Raised to Hold at Wall Street Zen

by · The Cerbat Gem

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday.

Separately, Lake Street Capital initiated coverage on Rapid Micro Biosystems in a report on Monday, July 28th. They issued a “buy” rating and a $8.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to data from MarketBeat, Rapid Micro Biosystems presently has a consensus rating of “Strong Buy” and a consensus target price of $8.00.

View Our Latest Analysis on RPID

Rapid Micro Biosystems Price Performance

Shares of NASDAQ RPID opened at $3.03 on Friday. The company has a 50-day simple moving average of $3.11 and a 200-day simple moving average of $2.92. Rapid Micro Biosystems has a 12 month low of $0.83 and a 12 month high of $4.50. The company has a market cap of $133.96 million, a PE ratio of -3.00 and a beta of 1.30.

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.01). Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%.The business had revenue of $7.26 million during the quarter, compared to analyst estimates of $7.10 million. Rapid Micro Biosystems has set its FY 2025 guidance at EPS. On average, analysts anticipate that Rapid Micro Biosystems will post -1.1 EPS for the current year.

Insider Transactions at Rapid Micro Biosystems

In other Rapid Micro Biosystems news, CEO Robert G. Jr. Spignesi sold 11,881 shares of the firm’s stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $3.32, for a total value of $39,444.92. Following the completion of the transaction, the chief executive officer owned 970,550 shares in the company, valued at $3,222,226. This trade represents a 1.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders sold 57,443 shares of company stock worth $195,952. Corporate insiders own 29.96% of the company’s stock.

Institutional Investors Weigh In On Rapid Micro Biosystems

Several institutional investors have recently added to or reduced their stakes in the company. American Century Companies Inc. purchased a new stake in shares of Rapid Micro Biosystems in the 1st quarter worth approximately $31,000. Legato Capital Management LLC acquired a new position in Rapid Micro Biosystems during the 1st quarter valued at approximately $41,000. Millennium Management LLC raised its position in Rapid Micro Biosystems by 17.6% during the fourth quarter. Millennium Management LLC now owns 61,375 shares of the company’s stock valued at $55,000 after acquiring an additional 9,191 shares in the last quarter. Citadel Advisors LLC purchased a new position in Rapid Micro Biosystems in the 4th quarter valued at about $65,000. Finally, XTX Topco Ltd acquired a new stake in shares of Rapid Micro Biosystems in the 2nd quarter worth $144,000. Hedge funds and other institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

(Get Free Report)

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Featured Articles